Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
19
Participants
Timeline
Start Date
March 31, 2002
Primary Completion Date
April 30, 2010
Study Completion Date
April 30, 2010
Conditions
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic CancerStage IV Pancreatic Cancer
Interventions
DRUG
paclitaxel
Given IV
DRUG
bryostatin 1
Given IV
Trial Locations (1)
10467-2490
Montefiore Medical Center, The Bronx
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00031694 - Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter